The post MYX Finance’s liquidity sweep holds, yet $6.40 caps price: How? appeared on BitcoinEthereumNews.com. Recent MYX Finance [MYX] momentum has shifted focusThe post MYX Finance’s liquidity sweep holds, yet $6.40 caps price: How? appeared on BitcoinEthereumNews.com. Recent MYX Finance [MYX] momentum has shifted focus

MYX Finance’s liquidity sweep holds, yet $6.40 caps price: How?

Recent MYX Finance [MYX] momentum has shifted focus toward a potential breakout zone. MYX swept liquidity within the $4.58–$4.63 zone, triggering a sharp rebound as bids reacted at the range floor.

Price then advanced, yet repeated rejection near $6.20–$6.40 capped upside, sustaining consolidation. Each pullback held above $4.63, signaling firm spot demand and persistent order-book support.

Wicks in the sweep zone suggested absorption rather than panic selling.

Source: TradingView

As price rotated between support and supply, structure remained range-bound, not trend-decisive. Liquidation clusters around the lows appeared partially cleared, reducing immediate downside fuel.

Still, failure to reclaim $6.40 kept momentum contained, leaving accumulation versus reactive dip-buying unresolved within the current range.

THIS overhead supply restrains breakout structure

MYX advanced into the $6.20–$6.40 resistance band multiple times, yet each attempt met firm sell-side pressure. Price printed sharp upper wicks near $6.30, reflecting active distribution rather than sustained acceptance.

As rallies stalled, pullbacks rotated price toward the $5.16 pivot, preserving range structure instead of breakout continuation. Volume expanded during rejection phases, signaling sellers absorbed upside liquidity rather than exhausting supply.

Meanwhile, MACD momentum began flattening after earlier expansion.

Source: TradingView

Histogram bars compressed toward neutral, indicating slowing upside strength. This alignment suggested momentum cooled as supply dominated overhead.

Sell-side absorption remained limited, with supply refilling on each resistance test. For bullish continuation, the price required decisive, high-volume acceptance above $6.40.

Until then, the persistent supply overhang continued suppressing upside extension and kept MYX locked within a capped trading range.

Decoding MYX’s structural liquidity formation

MYX Finance’s Perpetual Volume grew rapidly from very low levels into a steady $250 million to $300 million daily base, signaling strong derivatives adoption.

Spikes near $450 million to $500 million appeared at intervals, reflecting short bursts of speculative positioning rather than purely organic flow.

Source: DeFiLlama

After this expansion, volume stabilized instead of falling, indicating sustained platform usage.

Wider market data supported this trend. Total Perp Volume reached $70.45 billion in 24 hours, at press time, while 30-day activity exceeded $1.06 trillion, alongside $13.1 billion in Open Interest.

Source: DeFiLlama

This alignment pointed to broader derivatives market growth, not isolated platform activity.

However, stabilization within the mid-range suggested balanced two-way trading rather than strong directional conviction.

Sustained turnover reflected regular usage, while periodic spikes highlighted tactical leverage deployment within an expanding liquidity environment.


Final Thoughts

  • A break above $6.40 will determine whether the liquidity sweep evolves into a sustained bullish expansion.
  • Sustained perp volume strength positions MYX for volatility expansion once directional conviction returns.
Next: Ethereum fails at $2.5K: How $466M in liquidations crushed ETH

Source: https://ambcrypto.com/myx-finances-liquidity-sweep-holds-yet-6-40-caps-price-how/

Market Opportunity
MYX Finance Logo
MYX Finance Price(MYX)
$5.58128
$5.58128$5.58128
-5.66%
USD
MYX Finance (MYX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The Silver Price Doesn’t Look Real – And This Video Explains Why

The Silver Price Doesn’t Look Real – And This Video Explains Why

The Silver (XAG) price has been acting strange lately. Just when it looked like the market was settling down, a new argument started spreading fast: silver might
Share
Captainaltcoin2026/02/11 04:00
Will XRP Price Increase In September 2025?

Will XRP Price Increase In September 2025?

Ripple XRP is a cryptocurrency that primarily focuses on building a decentralised payments network to facilitate low-cost and cross-border transactions. It’s a native digital currency of the Ripple network, which works as a blockchain called the XRP Ledger (XRPL). It utilised a shared, distributed ledger to track account balances and transactions. What Do XRP Charts Reveal? […]
Share
Tronweekly2025/09/18 00:00
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11